| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |